Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Julio dos Anjos
Professional Services Consultant
Connect with Julio dos Anjos on LinkedIn
About the author:
Júlio dos Anjos implemented databases and information products for academic and hospital libraries for 20 years before joining Elsevier 4 years ago. Since then he implemented Pharmacovigilance solutions for multiple companies. He is now the lead consultant for Pharmacovigilance in the Elsevier R&D Professional Services team.
Online Drugstore, cialis black buy, Free shipping, domperidone online, Discount 10%, xeloda online cheap
Posts by Julio dos Anjos
Posted on February 29th, 2016 in Pharmacovigilance
A reasonable number of Market Authorization Holders (MAHs) have no ready answer to justify why they use a specific search formula for each specific product when Audit or Inspection time comes: (more…)
Posted on October 27th, 2015 in Pharmacovigilance
Although, quite a lot of existing flows have to change and new ones have to be implemented, there are, also, quite a lot of benefits, most of them for EMA, and some, not so obvious, for the MAH’s. Of these last ones, many are found by looking at the information, now made available by EMA, as an information professional in a pharmacovigilance context, as well as a pharmacovigilance analyst in an information rich environment.